This paper provides an overview of the role of data monitoring committees in ensuring patient safety and validity and scientific merit of the trial. This more formalized data monitoring approach tends to be used only in trials where there is a lot at stake. Use of data monitoring committees at the National Institutes of Health and results of a workshop held on the subject are covered.
Organization, Review and Administration of Cooperative Studies (Greenberg Report): A report from the Heart Special Project Committee to the National Advisory Heart Council, May 1967. Control Clin Trials.1988;9:137–148.
2.
ISIS-1 (First International Study of Infarct Survival) Collaborative Group.Randomized trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction: ISIS-1. Lancet.1980;2:57–66.
3.
ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.Randomized trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet.1988;2: 359–360.
4.
ISIS-3 (Third International Study of Infarct Survival) Collaborative Group.A randomized comparison of streptokinase vs. tissue plasminogen activator vs. anistreplase and of aspirin plus heparin vs. aspirin among 41,299 cases of suspected acute myocardial infarction: ISIS-3. Lancet.1992; 339:753–770.
5.
ISIS-4 (Fourth International Study of Infarct Survival) Collaborative Group.A randomized factorial trial assessing early oral Captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction: ISIS-4. Lancet.1995;345:669–685.
6.
EllenbergSSGellerNSimonRYusufS. (eds): Practical issues in Data Monitoring of Randomized Clinical Trials (workshop proceedings). Stat Med.1993;12:415–616.
7.
GreenSJFlemingTRO'FallonJR. Policies for study monitoring and interim reporting of results. J Clin Oncology.1987;5:1477–1484.
